Cytomegalovirus disease in patients with glomerular diseases treated by immunosuppressive treatment

Celebi Z. K., Calayoglu R., Yalci A. K., Akturk S., ŞENGÜL Ş., KUTLAY S., ...Daha Fazla

INTERNATIONAL UROLOGY AND NEPHROLOGY, cilt.46, sa.12, ss.2357-2360, 2014 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 46 Sayı: 12
  • Basım Tarihi: 2014
  • Doi Numarası: 10.1007/s11255-014-0849-0
  • Dergi Adı: INTERNATIONAL UROLOGY AND NEPHROLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.2357-2360
  • Anahtar Kelimeler: Cytomegalovirus, Glomerulonephritis, Immunosuppressive treatment, Renal failure, KIDNEY-TRANSPLANT RECIPIENTS, RENAL-TRANSPLANTATION, CMV INFECTION, TURKEY, GLOMERULONEPHRITIS, SEROPREVALENCE, CLASSIFICATION, VALACYCLOVIR, PREVENTION, PREVALENCE
  • Ankara Üniversitesi Adresli: Evet

Özet

Cytomegalovirus (CMV) infection is an important complication in organ and bone marrow recipients as well as patients infected with HIV. Although screening and prophylaxis have been defined in these patients, there are few data about the frequency of CMV disease in glomerular diseases treated by immunosuppression.